Healthcare

By

Meena Krishnamsetty

 | Mar 6, 2013 | 1:30 PM EST

An insider is buying, but recent margin trends get poor marks.

By

Chris Laudani

 | Mar 5, 2013 | 5:00 PM EST

The momentum favorite gets slammed on news of an FDA investigation.

By

Kate Stalter

 | Feb 14, 2013 | 12:30 PM EST

The generic drugmaker shows new signs of life after months of struggle.

By

Robert Moreno

 | Feb 11, 2013 | 1:30 PM EST

These two stocks have been consolidating and now appear ready to move in opposite directions.

By

Paul Price

 | Jan 30, 2013 | 6:45 PM EST

ESRX still has a a historically low valuation.

By

Paul Price

 | Jan 30, 2013 | 10:00 AM EST

The fear of 'dead money' has brought Quest back to an extremely low-risk entry point.

By

Paul Price

 | Jan 28, 2013 | 12:00 PM EST

This is one of the few stocks still trading at a bargain valuation.

By

Robert Moreno

 | Jan 24, 2013 | 1:30 PM EST

Action on the weekly chart of the managed-care provider appears constructive.

By

Kate Stalter

 | Dec 28, 2012 | 2:00 PM EST

Cognizant and Valeant earnings rose in 2012 and see growth up 17% and 24% in 2013.

By

Paul Price

 | Dec 19, 2012 | 10:00 AM EST

This stock is a steady climber, and it's at a glaring entry point.

A Special Thank You to Barron's

By

Brian Sozzi

 | May 18, 2013 | 6:48 AM EDT
I greatly appreciate the team for sharing my remembrance to Alan Abelson. It really did come from the heart. I am becom...

How to Obliterate an Earnings Call

By

Brian Sozzi

 | May 18, 2013 | 6:33 AM EDT
I approach an earnings call as I do eating a lobster: tear it apart and leave nothing for the dogs in the back alley. ...

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.